What does AMRN mean in UNCLASSIFIED
AMRN stands for Amarin Corporation. Founded in 1990, Amarin is a biopharmaceutical company located in Dublin, Ireland. The company specializes in the development and commercialization of therapeutic drugs to help improve cardiovascular health around the world. AMRN strives to make better treatments available and accessible to all types of patients. Through clinical research and development, AMRN works hard to provide physicians and patients with new medicines that have potential benefits for a wide array of diagnoses.
AMRN meaning in Unclassified in Miscellaneous
AMRN mostly used in an acronym Unclassified in Category Miscellaneous that means Amarin
Shorthand: AMRN,
Full Form: Amarin
For more information of "Amarin", see the section below.
What Does AMRN Mean?
AMRN stands for Amarin Corporation, which is a biopharmaceutical research-driven company based out of Ireland that specializes in the development and commercialization of cardiovascular medicines to help improve patient outcomes worldwide. Amarin’s main focus is on cardiovascular health interventions, with drugs designed to reduce cholesterol levels, provide anti-inflammatory effects, and improve blood flow through vessels. The company also has other products in its pipeline such as an oral treatment for hypertension and a drug designed to reduce triglyceride levels among other therapeutic solutions targeting conditions relating to cardiovascular health concerns.
Essential Questions and Answers on Amarin in "MISCELLANEOUS»UNFILED"
What is Amarin?
Amarin is a biopharmaceutical company focused on cardiovascular health, with the goal of improving the treatment of heart disease. The company develops and markets prescription products based on its Vascepa® Omega-3 product and secured FDA approval in 2019 for Vascepa® as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia.
What is Vascepa?
Vascepa (icosapent ethyl) is a highly pure omega-3 fatty acid product that has been approved by the U.S. Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia. It is believed to be the only FDA-approved product containing pure EPA ingredient from fish oil that has been studied in multiple large clinical trials and shown to provide significant risk reduction when added to statin therapy in high-risk patients with persistent elevated triglycerides.
Where can I get Amarin products?
Amarin's products are available through most major US pharmacies. Patients can also obtain them directly from Amarin if their doctor has prescribed it or if they have an insurance coverage option available through Amarin's website or call center.
How does Vascepa work?
Vascepa works by reducing fatty acids like EPA, DHA, and ALA, which are found naturally in oily fish such as salmon, mackerel, herring, sardines, and anchovies. By reducing these fatty acids, it helps lower serum levels of triglycerides which can reduce inflammation and improve cardiovascular health outcomes long-term.
Is there any side effects associated with taking Vascepa?
Generally speaking most people tolerate Vascepa well without experiencing any serious side effects. However some people may experience mild to moderate digestive issues, such as abdominal pain, nausea or diarrhea; while other potential side effects include skin rash or itching, headache or dizziness. As always patients should consult their healthcare professional before starting any new medication regimen as individual reactions may vary from person to person.
How often should I take Vascepa?
It is recommended that you take one capsule of 1 gram once daily with food for best results depending on your medical condition and doctor’s advice/prescription instructions.
Final Words:
In summary, AMRN stands for Amarin Corporation which is a biopharmaceutical marketing company based out of Ireland dedicated towards improving patient outcomes through the development and commercialization of cardiovascular drugs targeting both high-risk patients as well as other populations looking for alternative treatments options when it comes treating their chronic conditions relating back to heart health issues.